18501236

Source:http://linkedlifedata.com/resource/pubmed/id/18501236

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0041703, umls-concept:C0231491, umls-concept:C0599755, umls-concept:C1456820
pubmed:issue	6
pubmed:dateCreated	2008-5-26
pubmed:abstractText	The study objective was to investigate responsiveness according to whether patients satisfy eligibility criteria from randomized controlled trials of tumor necrosis factor (TNF) antagonists in a multicentered US cohort.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/K23 AR054412-02, http://linkedlifedata.com/resource/pubmed/grant/K23AR054412
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-10075615, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-10622295, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-11053697, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-12102156, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-12176803, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-12528101, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-12571838, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-12730544, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-12784381, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-12784382, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-15290732, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-15640272, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-15866254, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-15934109, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-15942917, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16173246, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16239384, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16273793, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16273803, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16306476, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16339480, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16342095, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16393444, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16401811, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16478843, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16679432, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-16705046, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-17075823, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-17105853, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-17426065, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-7818569, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-7818570, http://linkedlifedata.com/resource/pubmed/commentcorrection/18501236-9551282
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0267200
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/TNFR-Fc fusion protein, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/adalimumab, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1555-7162
pubmed:author	pubmed-author:CohenStanley BSB, pubmed-author:Consortium of Rheumatology Researchers of North America Investigators, pubmed-author:GreenbergJeffrey DJD, pubmed-author:HarringtonThomasT, pubmed-author:KafkaShelly PSP, pubmed-author:KishimotoMitsumasaM, pubmed-author:KremerJoel MJM, pubmed-author:OlenginskiThomas PTP, pubmed-author:ReedGeorgeG, pubmed-author:StrandVibekeV
pubmed:issnType	Electronic
pubmed:volume	121
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	532-8
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:18501236-Adult, pubmed-meshheading:18501236-Aged, pubmed-meshheading:18501236-Antibodies, Monoclonal, pubmed-meshheading:18501236-Antibodies, Monoclonal, Humanized, pubmed-meshheading:18501236-Arthritis, Rheumatoid, pubmed-meshheading:18501236-Cohort Studies, pubmed-meshheading:18501236-Female, pubmed-meshheading:18501236-Humans, pubmed-meshheading:18501236-Immunoglobulin G, pubmed-meshheading:18501236-Male, pubmed-meshheading:18501236-Middle Aged, pubmed-meshheading:18501236-Multicenter Studies as Topic, pubmed-meshheading:18501236-Patient Selection, pubmed-meshheading:18501236-Randomized Controlled Trials as Topic, pubmed-meshheading:18501236-Receptors, Tumor Necrosis Factor, pubmed-meshheading:18501236-Reproduction, pubmed-meshheading:18501236-Treatment Outcome, pubmed-meshheading:18501236-Tumor Necrosis Factor-alpha, pubmed-meshheading:18501236-United States
pubmed:year	2008
pubmed:articleTitle	Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort.
pubmed:affiliation	New York University Hospital for Joint Diseases, New York, NY 10003, USA. Jeffrey.Greenberg@nyumc.org
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural